Clinical Trials Browser

Interventional × fosaprepitant × 1 year × Clear all

NCT04503668 2025-06-18

Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology Patients

Phase 3 Terminated

62 enrolled 16 charts

Gynecologic Cancer

NCT03578081 2025-04-06

Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy

Phase 3 Completed

690 enrolled 17 charts

Neoplasms